Nektar Therapeutics Reports Second Quarter 2010 Financial Results
Nektar Therapeutics Reports Second Quarter 2010 Financial Results
SAN CARLOS, Calif., July 28 /PRNewswire-FirstCall/ — Nektar Therapeutics (Nasdaq: NKTR) today reported its financial results for the second quarter ended June 30, 2010. Cash, cash equivalents, and short-term investments at June 30, 2010 were $338.2 million as compared to $362.0 million at March 31, 2010. Revenue for the second quarter of 2010 increased to $42.6 million as compared to $13.0 …
Read more on redOrbit
Related posts: